These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34959270)

  • 1. Excipient-Free Inhalable Microparticles of Azithromycin Produced by Electrospray: A Novel Approach to Direct Pulmonary Delivery of Antibiotics.
    Arauzo B; Lopez-Mendez TB; Lobera MP; Calzada-Funes J; Pedraz JL; Santamaria J
    Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies.
    Momin MAM; Rangnekar B; Sinha S; Cheung CY; Cook GM; Das SC
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31581469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections.
    Dimer F; de Souza Carvalho-Wodarz C; Haupenthal J; Hartmann R; Lehr CM
    Pharm Res; 2015 Dec; 32(12):3850-61. PubMed ID: 26113237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocrystal Agglomerates of Curcumin Prepared by Electrospray Drying as an Excipient-Free Dry Powder for Inhalation.
    Emami S; Hemmati Z; Yaqoubi S; Hamishehkar H; Alvani A
    Adv Pharmacol Pharm Sci; 2024; 2024():6288621. PubMed ID: 39281030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation.
    Mangal S; Nie H; Xu R; Guo R; Cavallaro A; Zemlyanov D; Zhou QT
    Pharm Res; 2018 Jan; 35(2):28. PubMed ID: 29374368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis.
    Momin MAM; Sinha S; Tucker IG; Doyle C; Das SC
    Int J Pharm; 2017 Aug; 528(1-2):107-117. PubMed ID: 28583333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
    Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(sebacic acid) microparticles loaded with azithromycin as potential pulmonary drug delivery system: Physicochemical properties, antibacterial behavior, and cytocompatibility studies.
    Knap K; Reczyńska-Kolman K; Kwiecień K; Niewolik D; Płonka J; Ochońska D; Jeleń P; Mielczarek P; Kazek-Kęsik A; Jaszcz K; Brzychczy-Włoch M; Pamuła E
    Biomater Adv; 2023 Oct; 153():213540. PubMed ID: 37429048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.
    Arora S; Haghi M; Young PM; Kappl M; Traini D; Jain S
    Expert Opin Drug Deliv; 2016; 13(2):183-93. PubMed ID: 26609733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization.
    Momin MAM; Adhikari BR; Sinha S; Larson I; Das SC
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
    Pai RV; Jain RR; Bannalikar AS; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and Characterization of Doripenem-Loaded Microparticles for Pulmonary Delivery.
    Yildiz-Peköz A; Akbal O; Tekarslan SH; Sagirli AO; Mulazimoglu L; Morina D; Cevher E
    J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):347-357. PubMed ID: 29877747
    [No Abstract]   [Full Text] [Related]  

  • 15. Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.
    Rangnekar B; Momin MAM; Eedara BB; Sinha S; Das SC
    Int J Pharm; 2019 Oct; 570():118689. PubMed ID: 31513868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering Alginate-Based Dry Powder Microparticles to a Size Suitable for the Direct Pulmonary Delivery of Antibiotics.
    Arauzo B; González-Garcinuño Á; Tabernero A; Calzada-Funes J; Lobera MP; Del Valle EMM; Santamaria J
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of low density azithromycin-loaded polycaprolactone microparticles for pulmonary delivery.
    Kasten G; Silva LF; Lemos-Senna E
    Drug Dev Ind Pharm; 2016 May; 42(5):776-787. PubMed ID: 26266961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-electrospraying technology as a novel approach for dry powder inhalation formulation of montelukast and budesonide for pulmonary co-delivery.
    Yaqoubi S; Adibkia K; Nokhodchi A; Emami S; Alizadeh AA; Hamishehkar H; Barzegar-Jalali M
    Int J Pharm; 2020 Dec; 591():119970. PubMed ID: 33059013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-spray dried resveratrol and budesonide inhalation formulation for reducing inflammation and oxidative stress in rat alveolar macrophages.
    Trotta V; Lee WH; Loo CY; Young PM; Traini D; Scalia S
    Eur J Pharm Sci; 2016 Apr; 86():20-8. PubMed ID: 26944422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of particle size of inhaled tobramycin dry powder on the eradication of Pseudomonas aeruginosa biofilms.
    Aljalamdeh R; Price R; Jones MD; Bolhuis A
    Eur J Pharm Sci; 2021 Mar; 158():105680. PubMed ID: 33346008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.